Click on the button under the session details to view the agenda.

Monday

Industry symposium – Novo Nordisk A/S

Industry symposium – Eli Lilly and Company

Industry symposium – Sanofi

Industry symposium – Abott Diabetes Care

Rethinking Obesity Management: From Biologic Complexity to Patient-Centered Care

Unlocking scalable T1D Autoantibody Testing in Clinical Care

Industry symposium – SIBIONICS

Obesity rewired – Live news and views

Industry symposium – Boehringer Ingelheim International GmbH

A new era in autoimmune T1D: Translating emerging potential into clinical reality with teplizumab

Non-steroidal MRAs – Expanding Cardiorenal Care in Diabetes and Beyond

Industry symposium – AstraZeneca

Industry symposium – Boehringer Ingelheim International GmbH

Injection Technique in Endocrine Therapy: Addressing Lipohypertrophy and Enhancing Outcomes Across Insulin and GLP-1 Injectables

Reducing acute pancreatitis through apoC-III inhibition in patients with severe hypertriglyceridemia

Tuesday

Hot Topic Session – Eli Lilly and Company

Arena Talk – Sanofi

Hot Topic Session – Sanofi

Arena Talk – Dexcom Inc.

Hot Topic Session – Novo Nordisk A/S

Arena Talk – Roche

Arena Talk – SERVIER

Finding, Staging and Managing Early-Stage T1D In the Real World: A Practical Evidence Update for 2026

The earlier, the longer, the better in Diabetes management

Industry symposium – Novo Nordisk A/S

Industry symposium – Abbott

Wednesday

Industry symposium – Merck Healthcare KGaA

At the Cutting Edge of Automated Insulin Delivery: CamAPS Liberty, Pregnancy and the Menstrual Cycle

Industry symposium – Roche

Arena Talk – Boehringer Ingelheim International GmbH

Hot Topic Session – Abbott

A new era in autoimmune T1D: Navigating the realities of teplizumab treatment

Hot Topic Session – Dexcom Inc.

BR1DGE Talk: Practical Guidance on Optimizing the Sustainability and Cost Effectiveness of T1D Screening

Hot Topic Session – Eli Lilly and Company

A New Direction in T1D? Redefining Success From Survival to Freedom

Muscle Health in Diabetes: A New Lever to Improve Glycemic Control and Patient Outcomes

Liver-Directed Approach to Moderate to Advanced MASH: Implications for Diabetes Specialists

Industry symposium – Novo Nordisk A/S

Industry symposium – Eli Lilly and Company

Thursday

Hot Topic Session – Novo Nordisk A/S

Turn Up the Volume or Fine-Tune the Balance? Debating GDMT for cardio-kidney protection

Hot Topic Session – Roche

Arena Talk – Insulet

Hot Topic Session – Abbott

Arena Talk – MiniMed

Industry symposium – Novo Nordisk A/S

Friday

Arena Talk – Dexcom Inc.

Hot Topic Session – MiniMed

Arena Talk – Dexcom Inc.